SCHEMBL29356907

SCHEMBL29356907

CCCCOC(=O)Nc1nc(Cl)c(C=O)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.54
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 4/20 0.53
NPC1 O15118 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
NFKB1 P19838 1/20 0.53
STAT1 P42224 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.49
HSD17B10 Q99714 2/20 0.47
MAPK1 P28482 1/20 0.46
CSNK2A2 P19784 1/20 0.45
CSNK2A1 P68400 1/20 0.45
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
GAA P10253 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655832 0.73 L3MBTL1 (0.56) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL3778015 0.72 TSHR (0.68) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL994563 0.69 RAB9A (0.55) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL5746819 0.68 RAB9A (0.58) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL2654505 0.67 L3MBTL1 (0.59) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL29353713 0.67 SMN1; SMN2 (0.64) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL29937254 0.66 ALDH1A1 (0.55) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL10809546 0.66 L3MBTL1 (1.00) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL2906397 0.65 RAB9A (0.51) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL6675218 0.65 TSHR (0.56) TSHRRAB9ASMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3941908-A1 COMPOUNDS AND USES THEREOF Yumanity Therapeutics, Inc. (US) 2022-01-26 EP disclosed